On Target Laboratories, Inc.

Our mission is to illuminate cancer intraoperatively so it can be removed completely.

[On Target Laboratories, Inc. @OnTargetLabs]

This #GivingTuesday, we encourage you to help make #lungcancer research a priority by sharing your story and contributing to research opportunities that help support families.

[GO2 for Lung Cancer @GO2forLungCancr]

Whether you're a person with lung cancer, a survivor, or a caregiver, your participation can help shape the future of lung cancer research!

Share your story with the Lung Cancer Registry. It’s quick and easy to get started!

https://t.co/egERdp869r

#LCAM #LCSM

[On Target Laboratories, Inc. @OnTargetLabs]

Screening for #lungcancer can help find cancers before they grow and spread, making treatment more manageable. Learn more about the latest screening guidelines from the American Cancer Society: https://t.co/7gZQ5GnRQ4

[On Target Laboratories, Inc. @OnTargetLabs]

Today we announced our receipt of a significant investment that will play a pivotal role in accelerating the commercialization of our FDA approved intraoperative molecular imaging agent. Learn more: https://t.co/GMwptpYmQV #SeeCancerInRealTime

[On Target Laboratories, Inc. @OnTargetLabs]

Anyone with lungs can get #lungcancer. More awareness is needed to overcome the stigma and increase federal funding for critical lung cancer research. This #LCAM, empower yourself and your loved ones by learning the facts at https://t.co/Y4y1iYsGs6. #LCSM

[On Target Laboratories, Inc. @OnTargetLabs]

Thank you @GO2ForLungCancr for sharing invaluable #lungcancer resources during #LCAM and beyond.

[GO2 for Lung Cancer @GO2forLungCancr]

Join us next Tuesday for our monthly virtual social to connect with fellow survivors, caregivers, and supporters.

Register today: https://t.co/41QBVvag9v

#GO2forLungCancer #LCSM

[On Target Laboratories, Inc. @OnTargetLabs]

Excited to attend the Southern Thoracic Surgical Association’s 70th Annual Meeting this week in Orlando. We look forward to sharing how our intraoperative molecular imaging agent can help surgeons #SeeCancerInRealTime.

[On Target Laboratories, Inc. @OnTargetLabs]

Nearly 250,000 Americans will be diagnosed with #lungcancer, the leading cause of #cancer death in the U.S. It is encouraging to see @POTUS recognizing November as Lung Cancer Awareness Month again. We're proud to be part of the fight to end this disease. https://t.co/31f4NmZzAU

[On Target Laboratories, Inc. @OnTargetLabs]

Meet the team: We thank our Vice President of Chemistry Manufacturing and Controls, Anne Fornicola, for her supervision of our product development and commercial supply chain. From manufacture of starting materials, to packaging of finished goods, we appreciate all that you do!

[On Target Laboratories, Inc. @OnTargetLabs]

This #OvarianCancerAwarenessMonth, we’re honored that our technology has allowed for advancements in the detection of #ovariancancer. We are committed in our mission to illuminate cancer intraoperatively so it can be removed completely. Learn more: https://t.co/nVFC21FwOv

[On Target Laboratories, Inc. @OnTargetLabs]

Meet the team: Accounting Manager Brittany Mitchell has a personal connection with #lungcancer that inspires her to help more patients through her work as an Accounting professional at On Target Laboratories. Thank you for all you do!

[On Target Laboratories, Inc. @OnTargetLabs]

We are proud to share that our intraoperative molecular imaging agent has been awarded a new technology add-on payment that provides payment to hospitals utilizing our technology during ovarian and lung cancer surgery. Learn more: https://t.co/4jgPlWJfno

[On Target Laboratories, Inc. @OnTargetLabs]

On this World Lung Cancer Day, we remain committed to supporting people living with #lungcancer like Terri Ann. We’re honored to be a part of the community and are steadfast in our mission to illuminate cancer intraoperatively so it can be removed completely. #WLCD

[On Target Laboratories, Inc. @OnTargetLabs]

Meet the Team: Our Vice President of Sales David R. Hewitt is motivated to help more patients achieve optimal outcomes through financial management and distribution of our intraoperative molecular imaging agents. Thank you for all you do!

[On Target Laboratories, Inc. @OnTargetLabs]

Dr. Linda Martin, Chief of Thoracic Surgery at the University of Virginia Health, explains how our intraoperative molecular imaging agents work during #cancersurgery. #SeeCancerInRealTime

[On Target Laboratories, Inc. @OnTargetLabs]

Meet The Team: Ian Laswell is our Vice President of Finance and has a passion for utilizing his strong expertise in financial stewardship to enable use of our intraoperative molecular imaging agents and ultimately make a positive impact on humanity. Thank you for all you do!

[On Target Laboratories, Inc. @OnTargetLabs]

As an advocate for the #lungcancer community, Terri Ann DiJulio shares how lung cancer stigma may be impacting screening and early detection. Learn more: https://t.co/6J57SyZA5x

[On Target Laboratories, Inc. @OnTargetLabs]

Meet The Team: Javier Balcells is our Sales Representative in the Southern region and has been an integral part of commercializing our intraoperative molecular imaging agent and an invaluable member of the On Target team. Thank you for all you do!

[On Target Laboratories, Inc. @OnTargetLabs]

Today is #WorldHealthDay and this year’s theme is #Healthforall. We support the World Health Organization in their efforts to promote health so people around the world can attain the highest level of health and well-being. Learn more: https://t.co/gtBOR6wC2i

[On Target Laboratories, Inc. @OnTargetLabs]

Meet The Team: Chris Syrus is our Midwest Sales Representative and has been an integral part of commercializing our intraoperative molecular imaging agent and an invaluable member of the On Target team. Thanks for all you do!

[On Target Laboratories, Inc. @OnTargetLabs]

We are so honored to have been involved in such an extraordinary event. Thank you @MoffittNews for allowing us to join the conversation as we discussed “A Brighter future for Ovarian Cancer”.